Cipla
Last update: February 17, 2020
Pharmaceuticals
India
Its 22 main executivesIts subsidiary
Create an alert
to follow the executive moves at Cipla.
Latest M&A news in Pharmaceuticals.
Elanco has acquired Bayer Animal Health (posted on Aug 5, 2020).
F-star Biotechnology has announced the acquisition of Spring Bank (posted on Aug 3, 2020).
Croda International has announced the acquisition of Avanti Polar Lipids (posted on Jul 8, 2020).
Most searched biographies at Cipla
- Umang Vohra, Director, Chief Executive Officer and Managing Direct...
- Samina Vaziralli, Co-Vice Chairman of the Board
- Mustafa Hamied, Executive Vice-Chairman
Click on an executive to view his biography >
Other contacts in the Pharmaceuticals industry
Latest news about Cipla
Cipla receives regulatory approval for launch of Ciplenza (Favipiravir 200 mg) in India to treat mild to moderate COVID-19 | Cipla
Cipla receives final USFDA approval for generic version of Shire’s Firazyr® (Icatibant Injectable Pre-Filled Syringe 30mg/3mL) | Cipla
Cipla and Boehringer Ingelheim forge partnership to co-market three oral anti-diabetic drugs | Cipla
Cipla launches Cipremi (remdesivir lyophilised powder for injection 100 mg), the only U.S. FDA approved Emergency Use Authorisation (EUA) treatment for patients with severe COVID-19 disease | Cipla
Cipla expands partnership with Roche Pharma India to further improve access to key oncology medicines | Cipla
Cipla on Wikipedia, Google News & Yahoo Finance
Cipla on LinkedIn, Twitter & YouTube
Cipla has 2,020 competitors including Sun Pharma (India), Johnson & Johnson (United States (USA)) and Roche (Switzerland).
Contact by email its executives including Umang Vohra 
